What is AI Clinical Trial Pilot?

In practice, this term refers to using AI tools in a constrained trial setting, such as patient screening, protocol support, imaging triage, or monitoring study operations, while keeping humans responsible for clinical and regulatory decisions. A pilot should define scope, endpoints, datasets, validation methods, monitoring, rollback triggers, and documentation so the sponsor can show the system was tested under controlled conditions rather than deployed broadly without evidence.

For compliance teams, the key issue is that a pilot can trigger overlapping obligations around research governance, privacy, security, and product safety. Depending on the use case and jurisdiction, relevant frameworks may include EU AI Act obligations for high-risk health use cases, GDPR requirements for personal data processing, HIPAA where protected health information is involved, and ISO 27001 or ISO/IEC 42001 for security and management controls. In medical-device contexts, pilot evidence may also support clinical evaluation, postmarket planning, and change-control documentation.